Results 191 to 200 of about 280,195 (357)

Immune Checkpoint Inhibitors in Hodgkin Lymphoma and Non-Hodgkin Lymphoma

, 2022
Jiawen Huang, Juan Huang
openalex   +2 more sources

Simplified Molecular International Prognostic Index as an eligibility criterion for clinical trials: Analysis of the Turkish Lymphoma Study Group's large B‐cell lymphoma cohort

British Journal of Haematology, EarlyView.
The international prognostic index (IPI)‐driven trial inclusion criteria may have contributed to the failure of some of the first‐line trials in large B‐cell lymphoma (LBCL). GLA and LYSA collaborated to improve prognostic stratification in LBCL by analyzing data from trial cohorts and proposed the smIPI.
Umut Yılmaz, Esra Terzi Demirsoy, Fatma Keklik Karadağ, Uğur Hatipoğlu, Meral Uluköylü Mengüç, Ebru Pekgüç, Taner Tan, Eda Nuhoğlu Kantarcı, Metban Mastanzade, Ali Durdu, Merve Apaydın Kayer, Murat Özbalak, Tuğrul Elverdi, Asu Fergün Yılmaz, Deniz Gören, Tayfur Toptaş, Turgay Ulaş, Özgür Mehtap, Mehmet Sinan Dal, Olga Meltem Akay, Muhlis Cem Ar, Güray Saydam, Fevzi Altuntaş, Elif Birtaş Ateşoğlu, Burhan Ferhanoğlu   +24 more
wiley   +1 more source

A Milky Mystery: Chylothorax Unmasking Non-Hodgkin Lymphoma. [PDF]

Cureus
Tangutoori S, Gullapalli D, Kommineni SS, Gudipati MK, Depa J, Gaddam M, Ganti SS.   +6 more
europepmc   +1 more source

miR-103 promotes the progression of non-Hodgkins lymphoma by inhibiting OTUD7B expression

, 2020
Chong Wang, Yating Wu, Mengya Li, Shujuan Wang, Yanfang Liu   +4 more
openalex   +1 more source

The Impact of Advanced Patient Age on Mortality after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma: A Retrospective Study by the European Society for Blood and Marrow Transplantation Lymphoma Working Party [PDF]

, 2018
Charalampia Kyriakou, Ariane Boumendil, Hervé Finel, NN Norbert Schmitz, Niels Smedegaard Andersen, Didier Blaise, Patrice Chevallier, Paul Browne, Ram Malladi, Dietger Niederwieser, Antonio Pagliuca, Frank Kroschinsky, Silvia Montoto, Peter Dreger   +13 more
openalex   +1 more source

Follow‐up of osteonecrosis in paediatric acute lymphoblastic leukaemia patients treated with the NOPHO ALL2008 protocol

British Journal of Haematology, EarlyView.
Summary Although osteonecrosis (ON) is a common sequel after childhood acute lymphoblastic leukaemia treatment and may cause debilitating symptoms, its prognosis remains underexplored. We describe the radiological evolution of ON lesions in a Finnish patient cohort treated according to the The Nordic Society of Paediatric Haematology and Oncology ...
Roosa Rokkanen, Henri Aarnivala, Sanna Huhtaniska, Sauli Palmu, Tytti Pokka, Tuuli Pöyhönen, Maria Suo‐Palosaari, Pauliina Utriainen, Liisa Järvelä, Riitta Niinimäki   +9 more
wiley   +1 more source

HERV-K Envelope Induce a Humoral Response in Non-Hodgkin Lymphoma Patients. [PDF]

Curr Microbiol
Cossu I, Ruberto S, Filippi E, Simula ER, Noli M, Mottula A, Fozza C, Sechi LA.   +7 more
europepmc   +1 more source

Refining the risk stratification in advanced‐stage classical Hodgkin lymphoma: A critical analysis of clinical prediction models

British Journal of Haematology, EarlyView.
Comparative overview of three major prognostic models for advanced‐stage classical Hodgkin lymphoma (IPS‐7, IPS‐3 and A‐HIPI), summarizing their key variables, age ranges, validation scope and limitations. The figure also highlights future directions, including incorporation of dynamic biomarkers such as interim PET and the application of machine ...
Oguzhan Koca, Ahmet Emre Eskazan
wiley   +1 more source

Analysis of the efficacy and prognostic factors of gemcitabine combined with oxaliplatin in non-Hodgkin lymphoma. [PDF]

Oncol Lett
Zhang X, Li G, Liu F, Shi R, Wen J, Wu W, Dai J.   +6 more
europepmc   +1 more source

Recurrence of Non-Hodgkin Lymphoma at the Insulin Injection Site: Case Report

Orhan Türken, Şükrü Yıldırım, Gözde Şanlı, Rahmi Çubuk, G. Jarrar   +4 more
openalex   +2 more sources